U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN
Z845VHQ61P
Possibly Marketed Outside US
First approved in 2006
General
Record Details
Names
13
Classification
6
Identifiers
8
Subunits
1
Relationships
1
Active Moiety
1
Characteristic Attributes
2
HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN
Z845VHQ61P
Possibly Marketed Outside US
First approved in 2006
General
Approval Year
2006
178
Record Details
Substance Class
Protein
Protein Sub Type
Sequence Type
COMPLETE
Record UNII
Z845VHQ61P
Record Status
Validated (UNII)
Record Version
10
9
8
7
6
5
4
3
2
1
Names
13
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN
Common Name
English
GARDASIL 9 COMPONENT HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN
Common Name
English
HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN COMPONENT OF GARDASIL
Brand Name
English
SILGARD COMPONENT HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN
Brand Name
English
GARDASIL COMPONENT HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN
Brand Name
English
Showing 1 to 5 of 13 entries
Previous
1
2
3
Next
Classification
6
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Established Pharmacologic Class
Established Pharmacologic Class
[EPC]
Inactivated Human Papillomavirus Vaccine
[EPC]
NDF-RT
N0000183891
SEXUALLY TRANSMITTED DISEASES, VIRAL
EMA EPAR
DISEASES
MALE DISEASES OF THE UIRINARY AND REPRODUCTIVE SYSTEMS
GENITAL DISEASSES, MALE
SEXUALLY TRANSMITTED DISEASES
SEXUALLY TRANSMITTED DISEASES, VIRAL
CONDYLOMATA ACUMINATA
EMA ASSESSMENT REPORTS
SILGARD (AUTHORIZED: CONDYLOMATA ACUMINATA)
SEXUALLY TRANSMITTED DISEASES, VIRAL
EMA EPAR
DISEASES
MALE DISEASES OF THE UIRINARY AND REPRODUCTIVE SYSTEMS
GENITAL DISEASSES, MALE
SEXUALLY TRANSMITTED DISEASES
SEXUALLY TRANSMITTED DISEASES, VIRAL
CONDYLOMATA ACUMINATA
EMA ASSESSMENT REPORTS
GARDASIL (AUTHORIZED: CONDYLOMATA ACUMINATA)
Antigen
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Antigen
[C268]
Human Papillomavirus Antigen
NCI_THESAURUS
C75791
Papillomavirus vaccines
ATC
ANTIINFECTIVES FOR SYSTEMIC USE
VACCINES
VIRAL VACCINES
Papillomavirus vaccines
papillomavirus (human types 6, 11, 16, 18)
WHO-ATC
J07BM01
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Identifiers
8
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
DRUG BANK
DB10300
PRIMARY
EVMPD
SUB22592
PRIMARY
NDF-RT
N0000170916
PRIMARY
Vaccines, Inactivated [Chemical/Ingredient]
NDF-RT
N0000183364
PRIMARY
Actively Acquired Immunity [PE]
NDF-RT
N0000175336
PRIMARY
Papillomavirus Vaccines [Chemical/Ingredient]
Showing 1 to 5 of 8 entries
Previous
1
2
Next
Subunits
1
Relationships
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
589Y41968C
HUMAN PAPILLOMAVIRUS SEROTYPE 11 WHOLE
TARGET ORGANISM->VACCINE ANTIGEN
Showing 1 to 1 of 1 entries
Previous
1
Next
Active Moiety
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
Z845VHQ61P
HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN
ACTIVE MOIETY
Showing 1 to 1 of 1 entries
Previous
1
Next
Characteristic Attributes
2
Show
5
20
100
All
entries
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
MOL_WEIGHT:NUMBER(CALCULATED)
CHEMICAL
ESTIMATED 55800 Da (average)
Molecular Formula
CHEMICAL
ESTIMATED
C2486H3837O740N679S23
Showing 1 to 2 of 2 entries
Previous
1
Next
